| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872595 | The Annals of Thoracic Surgery | 2014 | 6 Pages |
Abstract
A remarkable number of patients survived 20 years or greater after heart transplantation, confirming the procedure as the gold standard for end-stage heart failure. Complications resulting from immunologic events and immunosuppressive therapy determine post-transplant mortality and morbidity. Due to improvements in immunosuppressive management in recent years, long-term survival is likely to increase.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hector MD, Simon H. MD, Maximilian Y. MD, PhD, Frank MD, Burkhardt PhD, Frank MD, PhD, Stephan MD, PhD, Mario L. MD, PhD, Volkmar MD, PhD, Markus J. MD, PhD,